Newz Quest

New Experimental Drug Enlicitide May Cut “Bad” Cholesterol By Up To 60%

November 11, 2025 | by Vanshika

N Shorts
New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.

Technically enhanced content presented under fair use in public-interest journalism.

Listen:

↓ Download Audio

RELATED POSTS

View all

view all
Choose Your Language »
Verified by MonsterInsights